International Clinical Trial: Mechanistic Study of Z-DNA Binding Protein 1 (ZBP1) in Immune Imbalance and Organ Injury in Systemic Lupus Erythematosus by Mediating Innate Immune Activation and Necroptosis

Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124887) titled 'Mechanistic Study of Z-DNA Binding Protein 1 (ZBP1) in Immune Imbalance and Organ Injury in Systemic Lupus Erythematosus by Mediating Innate Immune Activation and Necroptosis' on May 19.

Study Type: Observational study

Study Design: Case-Control study

Primary Sponsor: Beijing Hospital

Condition: Systemic lupus erythematosus

Intervention: Observation group:None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-06-01

Target Sample Size: Observation group:120;Control group:40;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=3...